VIE •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/20/2026 17:32
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeVIE
Market Capitalization27,172 mln
Float147 mln
Earnings Date10/29/2026
EPS
4.86
Stretched
P / E
38.47
Overvalued
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.51
Likely reliable
Relative Strength
89
/ 100
Strongly outperforming
Debt / Equity
0.44
Low leverage
Business Description
Biogen is a global biopharmaceutical company founded in 1978 and based in Cambridge, Massachusetts, focused on developing and delivering treatments for serious neurological and rare diseases, including multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and several other conditions. The company markets a broad portfolio of medicines and biosimilars across the United States, Europe, Asia, and beyond. Biogen works alongside a network of partners and collaborators to advance new therapies, including treatments for Dravet syndrome and other conditions that currently have few or no options available to patients.
